無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

スマートピルの世界市場の予測 (2017-2027年):カプセル内視鏡検査・ドラッグデリバリー・患者モニタリング

Smart Pill World Market Forecast 2017-2027: See Prospects for Capsule Endoscopy, Drug Delivery and Patient Monitoring in North America, South America, Europe, Asia-Pacific and the Rest of the World

発行 Visiongain Ltd 商品コード 599347
出版日 ページ情報 英文 133 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=145.96円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
スマートピルの世界市場の予測 (2017-2027年):カプセル内視鏡検査・ドラッグデリバリー・患者モニタリング Smart Pill World Market Forecast 2017-2027: See Prospects for Capsule Endoscopy, Drug Delivery and Patient Monitoring in North America, South America, Europe, Asia-Pacific and the Rest of the World
出版日: 2017年11月10日 ページ情報: 英文 133 Pages
概要

2017年の世界のスマートピルの収益規模は24億ドルを超えると推計されています。2027年にかけては力強い成長を遂げる見通しです。

当レポートでは、世界のスマートピルの市場を調査し、市場および製品の概要、製品タイプ・地域/主要国別の動向と市場規模の推移と予測、市場成長への影響因子および市場機会の分析、主要企業のプロファイルなどをまとめています。

第1章 レポート概要

第2章 イントロダクション

第3章 市場分析・予測

第4章 市場分析・予測:タイプ別

  • 概要
  • カプセル内視鏡検査
  • ドラッグデリバリー
  • 患者モニタリング

第5章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • その他

第6章 定性分析

  • ポーターのファイブフォース分析
  • 成長推進因子
  • 成長抑制因子
  • 市場機会

第7章 主要企業

  • Cerner Corporation
  • GE Healthcare
  • Proteus Digital Health, Inc
  • Boston Scientific Corporation
  • Capso Vision Inc.
  • 富士フイルムホールディングス
  • Medtronic PLC
  • Bio-Images Drug Delivery Limited (BDD)
  • Hoya Corporation (PENTAX MEDICAL)
  • オリンパス
  • その他

第8章 総論

第9章 用語

目次
Product Code: PHA0258

Discover How to Stay Ahead

Our 133-page report provides 129 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Smart Pill market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are forecasts for 3 Smart Pill Applications in the report at a global level:

Global Smart Pill Market by Application

  • Capsule Endoscopy
  • Drug Delivery
  • Patient Monitoring

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 6 major regional and 17 major national markets:

  • North America:
    • The US
    • Canada
    • Mexico
  • South America:
    • Brazil
    • Argentina
    • Bolivia
    • Paraguay
    • Rest of South America
  • Europe:
    • Germany
    • The UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific:
    • China
    • India
    • Japan
    • Thailand
    • Australia
    • Rest of Asia-Pacific
  • Middle East:
    • Africa
  • Other Countries (Rest of World)

The report also includes profiles and for some of the leading companies in the Smart Pill market, with a focus on this segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, the US, the UK and the APAC region in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth

Overall world revenue for Smart Pill will surpass $2.4bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Smart Pill Market report helps you

In summary, our 133-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for the Smart Pill market, with forecasts for 3 applications and 6 key regional and 17 major national markets - See forecasts for the Smart Pill market in North America, South America, Europe, Asia-Pacific, the Middle east and Africa, as well as the US, Canada, Mexico, Brazil, Argentina, Paraguay, Bolivia, Germany, France, the UK, Italy, France, Japan, China, India, Thailand and Australia.
  • What stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market - including company profiles for some of the major companies involved in the Smart Pill market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Smart Pill market and leading companies. You will find data, trends and predictions.

Get our report today Smart Pill Market World Market Forecast 2017-2027: See Prospects for Capsule Endoscopy, Drug Delivery and Patient Monitoring in North America, South America, Europe, Asia-Pacific and the Rest of the World.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Smart Pill Market Overview
  • 1.2 Research Methodology
    • 1.2.1 Primary Research
    • 1.2.2 Secondary Research
    • 1.2.3 Market Evaluation & Forecasting Methodology
  • 1.3 Global Smart Pill Market Segmentation
  • 1.4 Overview of Findings
  • 1.5 Why You Should Read This Report
  • 1.6 How This Report Delivers
  • 1.7 Key Questions Answered by This Analytical Report
  • 1.8 Frequently Asked Questions (FAQ)
  • 1.9 Who is This Report For?
  • 1.10 Associated Visiongain Reports
  • 1.11 About Visiongain

2. Introduction to the Smart Pill Market

3. Smart Pill Market Forecast to 2027

4. Smart Pill Market by Application: Market Forecast to 2027

  • 4.1 Overview
  • 4.2 Capsule Endoscopy
  • 4.3 Drug Delivery
  • 4.4 Patient Monitoring

5. Regional Smart Pill Market Forecasts to 2027

  • 5.1 Regional Smart Pill Market Forecast 2017-2027
  • 5.2 North American Smart Pill Market Forecast 2017-2027
    • 5.2.1 USA Smart Pill Market Forecast 2017-2027
    • 5.2.2 Canada Smart Pill Market Forecast 2017-2027
    • 5.2.3 Mexico Smart Pill Market Forecast 2017-2027
  • 5.3 South American Smart Pill Market Forecast 2017-2027
    • 5.3.1 Brazil Smart Pill Market Forecast 2017-2027
    • 5.3.2 Argentina Smart Pill Market Forecast 2017-2027
    • 5.3.3 Paraguay Smart Pill Market Forecast 2017-2027
    • 5.3.4 Bolivia Smart Pill Market Forecast 2017-2027
    • 5.3.5 Rest of South America Smart Pill Market Forecast 2017-2027
  • 5.4 European Smart Pill Market Forecast 2017-2027
    • 5.4.1 France Smart Pill Market Forecast 2017-2027
    • 5.4.2 Germany Smart Pill Market Forecast 2017-2027
    • 5.4.3 UK Smart Pill Market Forecast 2017-2027
    • 5.4.4 Spain Smart Pill Market Forecast 2017-2027
    • 5.4.5 Italy Smart Pill Market Forecast 2017-2027
    • 5.4.6 Rest of Europe Smart Pill Market Forecast 2017-2027
  • 5.5 Asia-Pacific Smart Pill Market Forecast 2017-2027
    • 5.5.1 China Smart Pill Market Forecast 2017-2027
    • 5.5.2 Japan Smart Pill Market Forecast 2017-2027
    • 5.5.3 India Smart Pill Market Forecast 2017-2027
    • 5.5.4 Australia Smart Pill Market Forecast 2017-2027
    • 5.5.5 Thailand Smart Pill Market Forecast 2017-2027
    • 5.5.6 Rest of Asia-Pacific Smart Pill Market Forecast 2017-2027
  • 5.6 Rest of World Smart Pill Market Forecast 2017-2027
    • 5.6.1 Middle East Smart Pill Market Forecast 2017-2027
    • 5.6.2 Africa Smart Pill Market Forecast 2017-2027
    • 5.6.3 Other Countries Smart Pill Market Forecast 2017-2027+

6. Smart Pill Market, Qualitative Analysis, 2017-2027

  • 6.1 Porter's Five Forces Analysis of the Smart Pill Market 2017-2027
    • 6.1.1 Bargaining Power of Buyers (Low)
    • 6.1.2 Bargaining Power of Suppliers (Medium)
    • 6.1.3 Threat of New Entrants (Low)
    • 6.1.4 Threat of Substitute Products (Medium)
    • 6.1.5 Intensity of Competitive Rivalry (Low)
  • 6.2 Drivers
    • 6.2.1 Increasing Incidence of GI Disease
    • 6.2.2 Growing Geriatric Population
    • 6.2.3 Technological Advancement
    • 6.2.4 Increasing Acceptance in GI Disease
  • 6.3 Restraints
    • 6.3.1 High Cost Associated With Capsule Endoscopy Procedures And Equipment
    • 6.3.2 Uncertain Reimbursement Policies
  • 6.4 Opportunities
    • 6.4.1 Untapped Market In Developed And Developing Economies
    • 6.4.2 Expansion In Therapeutic Application

7. Leading Companies in Smart Pill Market

  • 7.1 Cerner Corporation
    • 7.1.1 Cerner Corporation: Company Overview
    • 7.1.2 Cerner Corporation: Product Portfolio
    • 7.1.3 Cerner Corporation: Recent Developments
  • 7.2 GE Healthcare
    • 7.2.1 GE Healthcare: Company Overview
    • 7.2.2 GE Healthcare: Product Portfolio
    • 7.2.3 GE Healthcare: Recent Development
  • 7.3 Proteus Digital Health, Inc
    • 7.3.1 Proteus Digital Health, Inc: Company Overview
    • 7.3.2 Proteus Digital Health, Inc: Recent Developments
  • 7.4 Boston Scientific Corporation
    • 7.4.1 Boston Scientific Corporation: Company Overview
    • 7.4.2 Boston Scientific Corporation: Product Portfolio
    • 7.4.3 Boston Scientific Corporation: Recent Developments
  • 7.5 Capso Vision Inc.
    • 7.5.1 Capso Vision Inc.: Company Overview
    • 7.5.2 Capso Vision Inc.: Recent Developments
  • 7.6 Fujifilm Holdings Corporation
    • 7.6.1 Fujifilm Holdings Corporation: Company Overview
    • 7.6.2 Fujifilm Holdings Corporation: Product Portfolio
    • 7.6.3 Fujifilm Holdings Corporation: Recent Developments
  • 7.7 Medtronic PLC
    • 7.7.1 Medtronic PLC: Company Overview
    • 7.7.2 Medtronic PLC: Product Portfolio
    • 7.7.3 Medtronic PLC: Recent Developments
  • 7.8 Bio-Images Drug Delivery Limited (BDD)
    • 7.8.1 Bio-Images Drug Delivery Limited (BDD): Company Overview
  • 7.9 Hoya Corporation (PENTAX MEDICAL)
    • 7.9.1 Hoya Corporation: Company Overview
    • 7.9.2 Hoya Corporation: Product Portfolio
    • 7.9.3 Hoya Corporation: Recent Developments
  • 7.10 Olympus Corporation
    • 7.10.1 Olympus Corporation: Company Overview
    • 7.10.2 Olympus Corporation: Product Portfolio
  • 7.11 Other Companies of Interest in the Smart Pill Market

8. Conclusions

  • 8.1 Current Leading Segments
  • 8.2 Leading Regional Markets
  • 8.3 Emerging Markets
  • 8.4 The Future of the Market?

9. Glossary

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 3.1 Smart Pill Market, by Type, ($m), 2017-2027
  • Figure 4.1 Smart Pill Market, by Application, Market Share (%), 2016
  • Figure 4.2 Smart Pill Market, by Application, Forecast ($m) 2017-2027
  • Figure 4.3 Global Capsule Endoscopy for Smart Pill Market Forecast, by Geography, ($m) 2017-2027
  • Figure 4.4 Global Drug Delivery for Smart Pill Market Forecast, by Geography, ($m) 2017-2027
  • Figure 4.5 Global Patient Monitoring for Smart Pill Market Forecast, by Geography, ($m) 2017-2027
  • Figure 5.1 Global Smart Pill Market Forecast, by Geography, by Geography ($m) 2017-2027
  • Figure 5.2 Global Smart Pill Market Forecast, by Geography, Market Share (%), 2016
  • Figure 5.3 North America Smart Pill Market Forecast, by Country ($m) 2017-2027
  • Figure 5.4 North America Smart Pill Market, by Country, Market Share (%), 2016
  • Figure 5.5 USA Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.6 Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.7 Mexico Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.8 South America Smart Pill Market Forecast, by Country ($m) 2017-2027
  • Figure 5.9 South America Smart Pill Market, by Country, Market Share (%), 2016
  • Figure 5.10 Brazil Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.11 Argentina Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.12 Paraguay Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.13 Bolivia Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.14 Rest of South America Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.15 Europe Smart Pill Market Forecast, by Country ($m) 2017-2027
  • Figure 5.16 Europe Smart Pill Market, by Country, Market Share (%), 2016
  • Figure 5.17 France Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.18 Germany Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.19 UK Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.20 Spain Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.21 Italy Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.22 Rest of Europe Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.23 Asia-Pacific Smart Pill Market Forecast, by Country ($m) 2017-2027
  • Figure 5.24 Asia-Pacific Smart Pill Market, Market Share (%), 2016
  • Figure 5.25 China Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.26 Japan Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.27 India Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.28 Australia Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.29 Thailand Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.30 Rest of Asia-Pacific Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.31 RoW Smart Pill Market Forecast, by Country ($m) 2017-2027
  • Figure 5.32 Rest of World Smart Pill Market, by Country, Market Share (%), 2016
  • Figure 5.33 Middle East Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.34 Africa Smart Pill Market Forecast ($m) 2017-2027
  • Figure 5.35 Other Countries Smart Pill Market Forecast ($m) 2017-2027
  • Figure 6.1 Porter's Five Forces Analysis of the Smart Pill Market
  • Figure 7.1 Cerner Corporation, Revenue, ($million), 2012-2016
  • Figure 7.2 Cerner Corporation, Product Segments Share (%), 2016
  • Figure 7.3 GE Healthcare, Revenue, ($million), 2012-2016
  • Figure 7.4 GE Healthcare, Product Segments Share (%), 2016
  • Figure 7.5 GE Healthcare, Geographical Presence Share (%), 2016
  • Figure 7.6 Boston Scientific Corporation, Revenue, ($million), 2012-2016
  • Figure 7.7 Boston Scientific Corporation, Product Segments Share (%), 2016
  • Figure 7.8 Boston Scientific Corporation, Geographical Presence Share (%), 2016
  • Figure 7.9 Fujifilm Holdings Corporation, Revenue, ($million), 2012-2016
  • Figure 7.10 Fujifilm Holdings Corporation, Product Segments Share (%), 2016
  • Figure 7.11 Fujifilm Holdings Corporation, Geographical Presence Share (%), 2016
  • Figure 7.12 Medtronic PLC, Revenue, ($million), 2012-2016
  • Figure 7.13 Medtronic PLC, Product Segments Share (%), 2016
  • Figure 7.14 Medtronic PLC, Geographical Presence Share (%), 2016
  • Figure 7.15 Hoya Corporation, Revenue, ($million), 2014-2017
  • Figure 7.16 Hoya Corporation, Product Segments Share (%), 2016
  • Figure 7.17 Hoya Corporation, Geographical Presence Share (%), 2016
  • Figure 7.18 Olympus corporation, Revenue, ($million), 2013-2017
  • Figure 7.19 Olympus corporation, Product Segments Share (%), 2017
  • Figure 7.20 Olympus corporation, Geographical Presence Share (%), 2017
  • Figure 8.1 World Smart Pill, by Type, ($m), 2017-2027
  • Figure 8.2 World Smart Pill, by Geography, ($m), 2017-2027

List of Tables

  • Table 3.1. Smart Pill Market Forecast ($m, AGR%, CAGR%) 2017-2027
  • Table 4.1. Smart Pill Market Forecast, by Application ($m, AGR%, CAGR%) 2017-2027
  • Table 4.2 Global Capsule Endoscopy for Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 4.3 Global Capsule Endoscopy for Smart Pill Market Forecast, by Geography, ($m, AGR%, CAGR%) 2017-2027
  • Table 4.4 Global Drug Delivery for Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 4.5 Global Drug Delivery for Smart Pill Market Forecast, by Geography ($m, AGR%, CAGR%) 2017-2027
  • Table 4.6 Global Patient Monitoring for Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 4.7 Global Patient Monitoring for Smart Pill Market Forecast, by Geography ($m, AGR%, CAGR%) 2017-2027
  • Table 5.1 Smart Pill Market Forecast, by Geography ($m, AGR%, CAGR%) 2017-2027
  • Table 5.2 FDA Approved Capsule Endoscopes
  • Table 5.3 North America Smart Pill Market Forecast, by Country ($m, AGR%, CAGR%) 2017-2027
  • Table 5.4 USA Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.5 Canada Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.6 Mexico Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.7 South America Smart Pill Market Forecast, by Country ($m, AGR%, CAGR%) 2017-2027
  • Table 5.8 Brazil Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.9 Argentina Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.10 Paraguay Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.11 Bolivia Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.12 Rest of South America Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.13 EC Marked Capsule Endoscopy Systems
  • Table 5.14 European Smart Pill Market Forecast, by Country ($m, AGR%, CAGR%) 2017-2027
  • Table 5.15 France Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.16 Germany Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.17 UK Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.18 Spain Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.19 Italy Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.20 Rest of European Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.21 Asia-Pacific Smart Pill Market Forecast, by Country ($m, AGR%, CAGR%) 2017-2027
  • Table 5.22 China Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.23 Japan Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.24 India Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.25 Australia Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.26 Thailand Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.27 Rest of Asia-Pacific Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.28 Rest of World Smart Pill Market Forecast, by Country ($m, AGR%, CAGR%) 2017-2027
  • Table 5.29 Middle East Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.30 Africa Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 5.31 Other Countries Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
  • Table 7.1 Cerner Corporation: Company Overview
  • Table 7.2 Cerner Corporation: Product Portfolio
  • Table 7.3 Cerner Corporation: Recent Developments
  • Table 7.4 GE Healthcare: Company Overview
  • Table 7.5 GE Healthcare: Product Portfolio
  • Table 7.6 GE Healthcare: Recent Development
  • Table 7.7 Proteus Digital Health, Inc: Company Overview
  • Table 7.8 Proteus Digital Health, Inc: Recent Developments
  • Table 7.9 Boston Scientific Corporation: Company Overview
  • Table 7.10 Boston Scientific Corporation: Product Portfolio
  • Table 7.11 Boston Scientific Corporation: Recent Developments
  • Table 7.12 Capso Vision Inc.: Company Overview
  • Table 7.13 Capso Vision Inc.: Recent Developments
  • Table 7.14 Fujifilm Holdings Corporation: Company Overview
  • Table 7.15 Fujifilm Holdings Corporation: Product Portfolio
  • Table 7.16 Fujifilm Holdings Corporation: Recent Developments
  • Table 7.17 Medtronic PLC: Company Overview
  • Table 7.18 Medtronic PLC: Product Portfolio
  • Table 7.19 Medtronic PLC: Recent Developments
  • Table 7.20 Bio-Image Drug Delivery (BDD)oration: Company Overview
  • Table 7.21 Hoya Corporation: Company Overview
  • Table 7.22 Hoya Corporation: Product Portfolio
  • Table 7.23 Hoya Corporation: Recent Developments
  • Table 7.24 Olympus corporation: Company Overview
  • Table 7.25 Olympus corporation: Product Portfolio
  • Table 7.26 Other Companies for Smart Pill Market

Companies Listed

  • Abbott Laboratories
  • AbbVie, Inc.
  • Alkermes Plc
  • Amarin Corp. Plc
  • Amgen, Inc.
  • Amnis Corporation
  • Array BioPharma, Inc.
  • Associates Of Cape Cod Inc.
  • Astex Pharmaceuticals Inc.
  • AstraZeneca Plc
  • ASYMPTOTE LTD
  • Bayer AG
  • Bayer Corporation
  • Bayer HealthCare AG
  • Bayer Schering Pharma Aktiengesellschaft
  • BioLife Solutions, Inc.
  • BioMarin Pharmaceutical, Inc.
  • Biotest AG
  • Bristol-Myers Squibb Co.
  • Cardax, Inc.
  • Cardinal Health, Inc.
  • Ceapro, Inc.
  • Celgene Corp.
  • Cephalon, Inc.
  • Chugai Pharmaceutical Co., Ltd.
  • CK Life Sciences International (Holdings), Inc.
  • Consensys Imaging Service Inc.
  • Cornerstone Research & Development Inc.
  • Crescendo Bioscience, Inc.
  • CTI BioPharma Corp.
  • Deroyal Industries Inc.
  • Domain Therapeutics SA
  • Emd Millipore Corporation
  • Emd Serono Inc.
  • Endo International Plc
  • Evotec AG
  • Galderma Sa
  • GE Healthcare LTD
  • GlaxoSmithKline Plc
  • Henry Schein, Inc.
  • Hoya Corporation
  • Illumina, Inc.
  • Institut Bergonie
  • Janssen Biotech, Inc.
  • JHL Biotech, Inc.
  • Johnson & Johnson
  • Laboratoire Theramex
  • Laboratory Corp. of America Holdings
  • LifeWatch AG
  • Lombard Medical, Inc.
  • Lonza Group AG
  • McKesson Corp.
  • Medline Industries Inc.
  • Medtronic Plc
  • Merck KGaA
  • MorphoSys AG
  • Motion Picture And Television Fund
  • Myrexis, Inc.
  • Myriad Genetics, Inc.
  • NBTY, Inc.
  • Neptune Technologies & Bioresources, Inc.
  • Nexvet Biopharma PLC
  • Northwell Health Inc.
  • Novartis AG
  • Olympus Corporation
  • Opexa Therapeutics, Inc.
  • Otsuka Pharmaceutical Co. Ltd.
  • Owens & Minor, Inc.
  • Panacos Pharmaceuticals, Inc.
  • PELICAN HEALTHCARE LTD
  • Pfizer Inc.
  • Pharma Mar SA
  • Polymer Technology Systems Inc.
  • Progyny Inc.
  • Quanterix Corp.
  • Quest Diagnostics, Inc.
  • Smith & Nephew Plc
  • Spectrum Pharmaceuticals, Inc.
  • Vertex Pharmaceuticals, Inc.
  • Windtree Therapeutics, Inc.
  • Organisations Mentioned in this Report
  • European Medicines Agency
  • Food and Drug Administration (U S)
  • Ministry of Health, Labor and Welfare
  • National Cancer Institute
  • National Health Service (UK)
Back to Top